FATE — FATE THERAPEUTICS INC

Ownership history in Redmile Group, LLC  ·  43 quarters on record

This page tracks every 13F SEC filing in which Redmile Group, LLC reported a position in FATE THERAPEUTICS INC (FATE). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
17.24% (2021 Q4)
Avg. % of fund
4.95%
First filed
2015 Q2
Last filed
2025 Q4
Quarters held
43
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 UNCHANGED 12,872,946 — 0% 0.93% $12.6M $0.98
2025 Q3 UNCHANGED 12,872,946 — 0% 1.58% $16.2M $1.26
2025 Q2 UNCHANGED 12,872,946 — 0% 1.53% $14.4M $1.12
2025 Q1 UNCHANGED 12,872,946 — 0% 0.96% $10.2M $0.79
39 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    FATE price (monthly, adj. close)

Other funds also holding FATE

As of 2025 Q4 — sorted by position size

JOHNSON & JOHNSON 3Y 0.6% Bruce & Co., Inc. 3Y 7Y 0.22% Knott David M Jr 3Y 0.17% Monaco Asset Management SAM 3Y 0.14% DAFNA Capital Management LLC 3Y 7Y 0.13% Privium Fund Management B.V. 3Y 0.07% Vestal Point Capital, LP 0.06% TANG CAPITAL MANAGEMENT LLC 3Y 7Y 0.06% Parametrica Management Ltd 3Y 7Y 0.03% GSA CAPITAL PARTNERS LLP 3Y 7Y 0.02%
← Back to Redmile Group, LLC Holdings